EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990–2019

Farhad Tondro Anamag, Maryam Noori, Seyed Aria Nejadghaderi iD, Mark J M Sullman, Jessica A Grieger, Ali-Asghar Kolahi iD, Saeid Safiri iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.5743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Farhad Tondro Anamag und 6 weiteren Autor:innen. Beteiligte Einrichtung: Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, …. Hauptthemen laut MEDLINE: Blood Glucose, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The present study reported the cancer deaths and disability‐adjusted life years (DALYs) that were attributable to high fasting plasma glucose (HFPG) in the Middle East and North Africa (MENA) region by country, age, sex, cancer type and Socio‐demographic Index (SDI), from 1990 to 2019.

Methods

Global Burden of Disease (GBD) 2019 data were used to report the cancer‐related deaths and DALYs that were attributable to HFPG, for all MENA countries over the period 1990–2019. The results were presented as numbers, population attributable fractions (PAFs) and rates (per 100,000) with 95% uncertainty intervals.

Results

In 2019, there were an estimated 19.8 thousand (5.5–40.2) cancer deaths attributable to HFPG in MENA, which represents 4.7% (1.3–9.3) of all cancer‐related deaths. The number of regional DALYs due to HFPG‐related cancers was 462.2 thousand (127.3–959.5), which represents 3.8% (1.1–7.6) of all cancer‐related DALYs in 2019. From 1990 to 2019, the age‐standardized DALY rate of cancers attributable to HFPG (per 100,000) grew from 56.3 (14.6–121.1) to 107.0 (29.8–220.8), which was a 90.1% (64.4–127.8) increase. In 2019, the highest age‐standardized DALY rate of cancers attributable to HFPG was in Qatar (270.4) and the lowest was in Sudan (75.3). The DALY rate of cancers attributable to HFPG increased with age, peaking for males in the 70–74 age group and for females in the 75–79 age group, and then decreased for both sexes. A broadly positive relationship was found between the national SDI and the national age‐standardized DALY rate of all cancers attributable to FPG over the measurement period.

Conclusions

The burden of HFPG‐related cancers has increased over the past three decades in MENA, and was higher than the global average in multiple age groups. Implementing a battery of preventive measures and therapeutic interventions is suggested to address the adverse effects of this modifiable risk factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseNeoplasmsMaleFemaleHumansQuality-Adjusted Life YearsRisk FactorsAfrica, NorthernFastingMiddle EastGlobal Health

Stichwörter der Autor:innen

Eastern Mediterranean regionMiddle East and North Africacancerglobal burden of diseasehigh fasting plasma glucose

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.

ORCID-Profile: Seyed Aria Nejadghaderi, Ali-Asghar Kolahi, Saeid Safiri

Förderung

  • Shahid Beheshti University of Medical Sciences

Zitieren

APA

Tondro Anamag, F., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Grieger, J. A., Kolahi, A. A., & Safiri, S. (2023). Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990–2019. Cancer Medicine. https://doi.org/10.1002/cam4.5743

Vancouver

Tondro Anamag F, Noori M, Nejadghaderi SA, Sullman MJM, Grieger JA, Kolahi AA, et al. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990–2019. Cancer Medicine. 2023. doi:10.1002/cam4.5743

BibTeX
@article{TondroAnamag2023,
  author = {Tondro Anamag, Farhad and Noori, Maryam and Nejadghaderi, Seyed Aria and Sullman, Mark J M and Grieger, Jessica A and Kolahi, Ali-Asghar and Safiri, Saeid},
  title = {Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990–2019},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5743}
}
Kostenlos starten →